Sensimed SA, a Swiss company, has developed a unique technology platform on non-invasive soft contact lens-based solution. The first application, the SENSIMED Triggerfish®, provides an automated recording of continuous ocular dimensional change over 24 hours with the aim of revolutionizing glaucoma management enhancing personalization of patient care.
The SENSIMED Triggerfish® received the CE mark in 2010 and was approved by the U.S. Food and Drug Administration (FDA) in 2016. Since 2018 the device is registered in Japan at the Pharmaceuticals and Medical Devices Agency (PMDA).
Other non-invasive on-eye sensing applications are in development to provide clinically pertinent data with the same continuous monitoring approach. The Company is furthermore focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The data, analysed and modeled on an ongoing basis, is processed in an attempt to identify pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy of treatment.
The Company is directly positioned at the convergence between devices, treatment and information. Sensimed believes that with this global knowledge-based approach it will be possible to provide valuable insights that allow ophthalmologists to better understand and treat glaucoma.
Sensimed became a subsidiary of SEED CO., Ltd after the acquisition of a majority participation end of 2019.
The SENSIMED Triggerfish® received the CE mark in 2010 and was approved by the U.S. Food and Drug Administration (FDA) in 2016. Since 2018 the device is registered in Japan at the Pharmaceuticals and Medical Devices Agency (PMDA).
Other non-invasive on-eye sensing applications are in development to provide clinically pertinent data with the same continuous monitoring approach. The Company is furthermore focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The data, analysed and modeled on an ongoing basis, is processed in an attempt to identify pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy of treatment.
The Company is directly positioned at the convergence between devices, treatment and information. Sensimed believes that with this global knowledge-based approach it will be possible to provide valuable insights that allow ophthalmologists to better understand and treat glaucoma.
Sensimed became a subsidiary of SEED CO., Ltd after the acquisition of a majority participation end of 2019.
Location: Switzerland, Vaud, Etagnières
Employees: 11-50
Total raised: $3.31M
Founded date: 2003
Investors 2
| Date | Name | Website |
| - | BlueOcean ... | blueocean-... |
| - | Agate Medi... | agate-inve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.08.2010 | Series B | $3.31M | - |
Mentions in press and media 16
| Date | Title | Description |
| 10.09.2025 | The Race for Smart Contact Lenses: How XPANCEO Stacks Up Against Tech Giants | Share Share Share Share Email https://techbullion.com/ – October 2022 Smart contact lenses are becoming a battleground for tech innovators. These devices promise to overlay digital information directly onto our vision and even monitor our h... |
| 13.12.2019 | Japanese partner acquires Sensimed | |
| 09.10.2018 | Green light for Sensimed's smart contact lenses in Japan | |
| 13.12.2017 | The Last Mile to Civilization 2.0: Technologies From Our Not Too Distant Future | Developments in big data and bio-tech are ushering in a new age of consumer electronics that will bring civilization toward being a connected 'Internet of Things.' As technology migrates from our desktops and laptops to our pockets and bodi... |
| 07.03.2016 | FDA permits marketing of Sensimed’s Triggerfish | |
| 24.11.2015 | Swiss start-ups among the winners of the R&D 100 Award | |
| 08.07.2014 | Sensimed AG appoints David Bailey as new CEO and board member | |
| 11.02.2014 | Big Data in the eye: Contact lenses containing microsensors | By Mark Healey Sensors are touted as the way of the future for medicine. Eventually the entire physical exam may be replaced with more consistent and valid measures through the complete adoption of biological sensors. These devices are alre... |
| 16.01.2014 | Google’s New Smart Contact Lens Is Old News For Microsoft | Google today announced its smart contact lens project, but it’s not the first by a long shot (or even a moon shot). Other companies have long been working on smart lenses — including Microsoft Research, which unveiled a similar project in 2... |
| 01.02.2013 | Investment Record for EPFL Spin-offs |
Show more